To identify drugs that suppress SPP1 in melanoma, we performed a pilot screening using vemurafenib (BRAF inhibitor), trametinib (MEK inhibitor), and NHWD-870 (BET inhibitor) and found that NHWD-870 inhibited SPP1 expression (Figure 5A). Here, DNER is linked to melanoma.